Lonza Group AG
LONN
주식 순위
#445
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
주가
$763.79
시가총액
$53.35B
변동 (1일)
0.93%
변동 (1년)
8.56%
국가
CH
거래 Lonza Group AG (LONN)
카테고리
Healthcare
Lonza Group AG (LONN)의 주가 이력
최고 종가: $758.47 (2026-10-01 기준)
최저 종가: $55.45 (1999-11-01 기준)
최저 종가: $55.45 (1999-11-01 기준)
Lonza Group AG의 주가 이력 (1999 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | 2.71% |
| 2025 | 12.69% |
| 2024 | 52.26% |
| 2023 | -21.39% |
| 2022 | -38.27% |
| 2021 | 29.85% |
| 2020 | 78.48% |
| 2019 | 17.36% |
| 2018 | 12.75% |
| 2017 | 66.47% |
| 2016 | 7.54% |
| 2015 | 39.65% |
| 2014 | 24.10% |
| 2013 | 74.91% |
| 2012 | -11.33% |
| 2011 | -26.82% |
| 2010 | 12.01% |
| 2009 | -13.00% |
| 2008 | -29.50% |
| 2007 | 34.20% |
| 2006 | 46.37% |
| 2005 | 8.46% |
| 2004 | 5.02% |
| 2003 | -11.00% |
| 2002 | -13.66% |
| 2001 | 22.46% |
| 2000 | -6.51% |
| 1999 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $536.73 | 25.86% |
US
|
|
| $225.94 | 741.49% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $878.85 | 7.94% |
NL
|
